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Polyploidization can precede the development of
aneuploidy in cancer. Polyploidization inmegakaryo-
cytes (Mks), in contrast, is a highly controlled devel-
opmental process critical for efficient platelet
production via unknown mechanisms. Using primary
cells, we demonstrate that the guanine exchange
factors GEF-H1 and ECT2, which are often overex-
pressed in cancer and are essential for RhoA activa-
tion during cytokinesis, must be downregulated for
Mk polyploidization. The first (2N–4N) endomitotic
cycle requires GEF-H1 downregulation, whereas
subsequent cycles (>4N) require ECT2 downregula-
tion. Exogenous expression of both GEF-H1 and
ECT2 prevents endomitosis, resulting in proliferation
of 2N Mks. Furthermore, we have shown that the
mechanism by which polyploidization is prevented
in Mks lacking Mkl1, which is mutated in megakaryo-
cytic leukemia, is via elevated GEF-H1 expression;
shRNA-mediated GEF-H1 knockdown alone rescues
this ploidy defect. These mechanistic insights
enhance our understanding of normal versus malig-
nant megakaryocytopoiesis, as well as aberrant
mitosis in aneuploid cancers.
INTRODUCTION
Polyploidy resulting from cellular stress precedes aneu-
ploidy, which can lead to tumors associated with transfor-
mation to malignancy and a poor prognosis (Nguyen and
Ravid, 2006, 2010). In contrast, polyploidy of megakaryocytes
(Mks), the hematopoietic cells that give rise to platelets, is
a tightly controlled normal differentiation process. Diploid
megakaryoblasts differentiated from hematopoietic stem cells
undergo a progressive increase in ploidy (up to 128N) due to
repeated DNA replication without cell division, a process
termed endomitosis, resulting in large multilobulated, poly-
ploid nuclei (Battinelli et al., 2007). Polyploidization is essen-
tial for efficient platelet production. In megakaryoblasticDeveloleukemia, low-ploidy megakaryoblasts predominate (Raslova
et al., 2007).
Studies using time-lapse microscopy to observe endomitotic
Mks suggest that the initial endomitotic cleavage event in
which cells progress from 2N to 4N occurs due to failure at
late cytokinesis with normal cleavage furrow ingression fol-
lowed by furrow regression (Geddis et al., 2007; Papadantona-
kis et al., 2008; Lordier et al., 2008; Leysi-Derilou et al., 2010).
These endomitotic Mks form an apparently intact midzone with
normal localization of essential components including Survivin,
Aurora B, INCENP, PRC1 (protein-regulating cytokinesis 1),
MKLP1 and 2 (mitotic kinesin-like protein), MgcRacGAP, and
microtubules (Geddis and Kaushansky, 2006; Lordier et al.,
2008). During cytokinesis, RhoA signaling is required to estab-
lish the actomyosin ring at the cleavage furrow, generating the
contraction force for completion of cytokinesis (Bement et al.,
2005; Narumiya and Yasuda, 2006; Melendez et al., 2011). Acti-
vated RhoA and its effectors (ROCK, Citron, LIM, and mDia) are
localized to the cleavage furrow (Madaule et al., 1998; Yasui
et al., 1998; Kosako et al., 2000; Tolliday et al., 2002). Domi-
nant-negative Citron and ROCK inhibitors prevent normal cyto-
kinesis (Madaule et al., 1998; Kosako et al., 2000). In contrast
to normal cytokinesis, the contractile ring of Mks undergoing
endomitosis lacks nonmuscle myosin IIA and contains
decreased levels of RhoA and actin at the 2N–4N transition;
in higher ploidy cells, RhoA is not detectable at the cleavage
furrow during anaphase (Geddis and Kaushansky, 2006; Lor-
dier et al., 2008).
Rho family small GTPases (e.g., RhoA, Rac1, and Cdc42)
are molecular switches that regulate many cellular proces-
ses, including actin cytoskeleton reorganization, microtubule
dynamics, cell-cycle progression, and cytokinesis (Etienne-
Manneville and Hall, 2002). Rho GTPase switching from the
inactive GDP-bound state to the active GTP-bound state is
facilitated by a group of proteins called Dbl family guanine
nucleotide exchange factors (GEFs), which have a tandem
Dbl homology (DH)-Pleckstrin homology (PH) domain, in which
the DH domain contains GDP/GTP exchange activity (Ross-
man et al., 2005). GEFs are involved in RhoA localization and
activation during different stages of cytokinesis. Upon break-
down of the nuclear envelope during mitosis, the GEF ECT2
(epithelial cell-transforming sequence 2) is dispersed from the
nucleus to the cytoplasm, and recruited to the central spindlepmental Cell 22, 573–584, March 13, 2012 ª2012 Elsevier Inc. 573
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MgcRacGAP) during late anaphase for establishment of the
cleavage furrow (Petronczki et al., 2007; Yu¨ce et al., 2005).
ECT2, required for cell-cycle progression, is an oncogene
that resides on chromosome 3q26, a region frequently targeted
for chromosomal alterations in human tumors and overex-
pressed in some primary human tumors (Fields and Justilien,
2010; Iyoda et al., 2010). RNA interference (RNAi) knockdown
of ECT2 results in mitotic failure and binucleate cells due to
lack of cleavage furrow ingression (Birkenfeld et al., 2007).
There are multiple studies suggesting that ECT2 is important
for RhoA localization and activation during cleavage furrow
formation and ingression (Yu¨ce et al., 2005; Nishimura and Yo-
nemura, 2006; Yoshizaki et al., 2004), whereas some evidence
suggested that ECT2 may not be directly responsible for RhoA
activation during furrow ingression. Without ECT2, RhoA still
gets activated but is mislocalized from the cleavage furrow
(Chalamalasetty et al., 2006; Birkenfeld et al., 2007). An
N-terminal fragment of ECT2 lacking the catalytic DH/PH
domain can rescue the furrow ingression defect in ECT2
RNAi-treated cells (Chalamalasetty et al., 2006). Thus, ECT2
recruits RhoA to the cleavage furrow but may not directly cata-
lyze its activation.
The microtubule-associated protein GEF-H1 plays a critical
role in cytokinesis by activating RhoA at the cleavage furrow
(Birkenfeld et al., 2007). Association with polymerized micro-
tubules inactivates GEF-H1 (Krendel et al., 2002). A truncated
form of GEF-H1 lacking its microtubule-binding ability was
discovered in the monocytic leukemia cell line U937 and is
able to induce tumor formation in nude mice (Brecht et al.,
2005). Also, GEF-H1 is transcriptionally activated by mutant
p53, and its expression is strongly induced in mutant p53
cell lines, leading to accelerated tumor cell proliferation
(Mizuarai et al., 2006). During mitosis, GEF-H1 is first associ-
ated with the microtubule spindle, and later with the midbody
(Birkenfeld et al., 2007). The same authors also show that
GEF-H1 binding to microtubules is facilitated by phosphoryla-
tion at Ser885 and Ser959 by the mitotic kinases Aurora A/B
and Cdk1, respectively. At the onset of cytokinesis, GEF-H1
is dephosphorylated and released from microtubules so that
it can activate RhoA. In contrast to ECT2 RNAi, in which cyto-
kinesis is blocked and there is no cleavage furrow formation,
GEF-H1 knockdown causes a defect at a later stage of cytoki-
nesis—the cleavage furrow is induced normally, but the furrow
fails to close completely, resulting in binucleate cells (Birkenfeld
et al., 2007).
Because of the importance of mitotic GEFs in RhoA localiza-
tion and activation during cytokinesis, we hypothesized that
decreased RhoA activation in Mk endomitosis may be caused
by a decrease in mitotic GEFs. In the present work, we show
that both GEF-H1 and ECT2 are downregulated at the mRNA
and protein levels during Mk polyploidization. We show that
MKL1-regulated GEF-H1 downregulation is required for endomi-
tosis of 2N cells to become 4N, whereas ECT2 downregulation is
required for polyploidization beyond the 4N stage. Together,
these decreases in ECT2 and GEF-H1 are responsible for the
decreased RhoA signaling that occurs in endomitosis, and
downregulation of GEF-H1 represents one of the initiating events
of endomitosis.574 Developmental Cell 22, 573–584, March 13, 2012 ª2012 ElsevierRESULTS
Establishment of In Vitro Models to Study Mk
Endomitosis
We used primary murine Mks to study the involvement of Dbl
family GEFs in Mk endomitosis. The first endomitotic event
from 2N to 4N Mks occurs due to failure of cytokinesis at a late
stage of cytokinesis with cleavage furrow regression. In contrast,
there are different reports for when subsequent endomitotic
events driving 4N to higher ploidy Mks interrupt the normal cyto-
kinesis machinery. Some report significant cleavage furrow
formation for higher ploidy Mks (Lordier et al., 2008; Leysi-Deri-
lou et al., 2010), whereas others report little apparent cleavage
furrow formation in high-ploidy endomitosis (Geddis et al.,
2007; Papadantonakis et al., 2008). Therefore, we first examined
how primary mouse Mks undergo endomitosis at different
stages using Mks from GFP-tagged Histone 2B (H2B-GFP)
transgenic mice visualized by time-lapse microscopy for
changes in both chromatin and cell morphology during endomi-
tosis. Mk progenitors (MkPs; Lin-Sca-Kit+CD41+) sorted from
bone marrow (BM) were cultured in TPO-only differentiation
medium (DM) to promote Mk polyploidization. MkP endomitotic
events were recorded by time-lapse microscopy, and 2N, 4N,
and higher ploidy MKs were distinguished based on division
history as well as their cell size after mitosis or endomitosis,
a method established previously (Levine et al., 1982; Leysi-Deri-
lou et al., 2010; Tomer, 2004; Tomer et al., 1988). Of the 2N cells
(24 events) whose DNA division events we observed, 80% of 2N
DNA divisions resulted in endomitosis with clear cleavage furrow
formation followed by regression and formation of 4N cells (Fig-
ure 1A; seeMovie S1 available online), 7% of 2N cells underwent
endomitosis without significant cleavage furrow ingression, and
13% of 2N cells underwent normal mitosis with complete cytoki-
nesis. In contrast, for division of cells that started out withR4N
DNA (37 events), 86% of divisions were endomitotic without
noticeable cleavage furrow ingression (Figure 1B; Movie S2),
and 14% were endomitotic with significant cleavage furrow
ingression followed by regression. Our data confirm that there
are two distinct phases of endomitosis in mouse primary Mks:
for the 2N to 4N transition, the cleavage furrow forms but fails
to complete cytokinesis; and for R4N endomitosis, there is
usually, but not always, little to no cleavage furrow ingression.
RhoA Is Not Activated at the Cleavage Furrow during
Endomitosis
RhoA activity is important for cleavage furrow ingression during
cytokinesis. To understand the mechanisms underlying the
failure to complete cytokinesis in 2N to 4N Mk endomitosis, we
assayed localization of active RhoA during endomitosis using
a FRET-based RhoA biosensor. The biphenotypic Mk-erythroid
progenitor population as defined by Akashi et al. and refined
(Lin-Sca-Kit+CD41CD150+CD105) and renamed ‘‘PreMegE’’
by Pronk et al. (Akashi et al., 2000; Pronk et al., 2007) was sorted
from BM. To assess RhoA activation directly, a widely used
single-molecule RhoA activation FRET probe (Birkenfeld et al.,
2007; Pertz et al., 2006), pBabe-Puro-RhoA Biosensor, was
transduced into primary mouse PreMegEs that were then
cultured in growth medium (GM) (Figure 2A) or DM (Figure 2B),
and the FRET efficiencies (FRET/CFP ratio) were determinedInc.
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Figure 1. Endomitosis of MkPs Induced by TPO
(A) 2N to 4N Mk endomitosis shows cleavage furrow
ingression with subsequent regression, resulting in one
4N cell.
(B) 4N to 8N Mk endomitosis showing no apparent
cleavage furrow. The figures show overlays of DIC (gray)
with green fluorescent H2B-GFP (green) images taken
every 5 min. The time of each image relative to the first is
indicated in each frame.
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scanning microscope equipped with temperature and CO2
control. Total RhoA localization was assessed by analysis of
the CFP signal from the RhoA biosensor, which reflects the
endogenous RhoA localization during mitosis as reported previ-
ously (Birkenfeld et al., 2007; Pertz et al., 2006). PreMegE
cultured in GM with SCF, TPO, IL-3, and Flt-3 served as normal
mitotic controls (Figure 2A). Under these conditions, 100% of
2N cells undergoing mitosis complete cytokinesis (data not
shown). From early to late cytokinesis, the RhoA biosensor is
enriched at the equatorial cortex (Figures 2Ai and 2Aiii) as previ-
ously reported (Yu¨ce et al., 2005). When MkPs are cultured in
DM, 80% of DNA divisions result in endomitosis, and during
endomitotic anaphase and cytokinesis, RhoA is similarly present
throughout the cytoplasm including at the equatorial region at
early cytokinesis (Figures 2Bi and 2Biii), which is consistent
with previous reports that RhoA localizes correctly during 2N
endomitosis by immunofluorescence of fixed Mks (Geddis and
Kaushansky, 2006; Lordier et al., 2008). To determine whether
RhoA protein levels change during Mk differentiation, RhoA
protein from different stages of Mk differentiation as well as in
platelets was analyzed by western blotting. As shown in Fig-
ure S1, total RhoA protein was only slightly decreased (20%)
during Mk differentiation, which is in agreement with the almost
constant level of RhoA duringMk differentiation of CD34+ human
blood cells (Chang et al., 2007).
In PreMegE undergoing cytokinesis, there is a high FRET
signal at the cleavage furrow (Figures 2Aii and 2Aiv) indicating
high RhoA activity in this region, in agreement with published
data on RhoA activation during cytokinesis in NIH 3T3 cells
(Yoshizaki et al., 2003). However, in Mks undergoing endomi-
tosis, there was no significant FRET signal in this region (Figures
2Bii and 2Biv), indicating lack of RhoA activation at the cleavageDevelopmental Cell 22, 5furrow, which provides direct evidence that
during 2N to 4N endomitosis, there is a failure
of RhoA activation at the cleavage furrow,
even though RhoA is localized correctly to this
region.
GEF-H1 and ECT2 Levels Decrease
during Mk Polyploidization
To investigate the mechanisms underlying the
failure of RhoA activation in Mks during endomi-
tosis of 2N cells, and the absence of RhoA
protein at the cleavage furrow region during
endomitosis of higher ploidy cells, we assessed
whether the mitosis-associated GEFs, ECT2
and GEF-H1, are differentially expressed duringMk differentiation. Wild-type (WT) PreMegEs and MkPs were
cultured in DM, and RNA expression was assessed by quantita-
tive RT-PCR over time. As shown in Figures 3A and 3B, MkPs
had lower levels of both GEF-H1 and ECT2 mRNA compared
with PreMegE. TPO treatment of PreMegE decreases GEF-H1
and ECT2 mRNA levels by 67% and 78%, respectively.
GEF-H1 mRNA levels subsequently increased after prolonged
TPO exposure when high-ploidy Mks were forming, whereas
ECT2 mRNA levels remained low. GEF-H1 and ECT2 protein
levels also decreased (Figure 3C) but with slightly different
kinetics than the mRNA: GEF-H1 protein reached a nadir after
1 day of culture of PreMegE in TPO medium, and then began
to increase; in contrast, ECT2 protein levels were significantly
decreased after 2 days and then remained low.
GEF-H1 and ECT2 Levels during Endomitosis
ECT2 expression is induced by growth factors that promote cell-
cycle entry, and cells in G0 have little ECT2 (Saito et al., 2003).
However, it is unlikely that decreased GEF-H1 and ECT2 levels
during TPO-induced Mk differentiation are caused by cell-cycle
exit. First, TPO induces MkP cell cycling (Drayer et al., 2006).
Second, the level of Anillin protein, an indicator of mitotic activity,
which peaks in mitosis and decreases dramatically upon mitotic
exit (Zhao and Fang, 2005), increased dramatically uponMk TPO
treatment (Figure S1), indicating increased cell cycling after TPO
treatment. To directly confirm that Mks undergoing the cell cycle
have decreasedGEF-H1 and ECT2 levels, we examined GEF-H1
and ECT2 protein in endomitoticMks by immunofluorescence. In
mitotic control cells (PreMegEs in GM for 1 day), the microtubule
spindle is normal, and GEF-H1 colocalizes with the microtubule
spindle as reported previously (Birkenfeld et al., 2007) (Figures
4Ai–4Aiii). In contrast, in endomitotic MkPs cultured in DM for
1 day, the GEF-H1 protein level is low with little fluorescence73–584, March 13, 2012 ª2012 Elsevier Inc. 575
Figure 2. Active RhoA Is Absent from the Cleavage
Furrow during the First Endomitotic Cleavage
Mouse primary PreMegE cells were transduced with the
RhoA biosensor virus for 48 hr before switching to fresh
GM (A) or DM (B). After 8 hr, the RhoA activation pattern
throughout mitosis (A) or endomitosis (B) was assessed.
The CFP channel indicates biosensor (and RhoA) locali-
zation (i, iii, and v). The RhoA activation pattern was
ssessed by the RhoA biosensor’s FRET/CFP ratio (FRET).
The red color in FRET images indicates high RhoA acti-
vation (ii, iv, and vi). All images were processed identically.
Elapsed time (minutes) with starting time set to zero (0)
(8 hr post-TPO administration) is indicated in each picture.
Images are representative of at least four similar obser-
vations for each condition.
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2 days in DM, in polyploid (>4N) cells undergoing anaphase, the
spindle appeared normal, and GEF-H1 protein was again easily
detected with localization to the microtubule spindle (Figures
4Avii–4Aix). The relative increase in GEF-H1 was consistent
with the changes in protein levels detected by western blotting
(Figure 3C). In PreMegE mitosis controls, ECT2 localized to the
central spindle (Figures 4Bi–4Biii) as published previously (Tat-
sumoto et al., 1999; Yu¨ce et al., 2005). During 2N to 4N endomi-
tosis of MkPs, ECT2 was easily detected and localized to the
central spindle (Figures 4Biv–4Bvi). The immunofluorescence
signal between these two samples did not show any apparent
differences (Figures 4Bi and 4Biv), although the ECT2 protein
level in MkPs is about 30% lower than that of PreMegE by
western blot (Figure 3C). In high-ploidy cells, ECT2 protein levels
were very low (Figures 4Bvii–4Bix), which is in agreement with
the western blot data (Figures 3C and S1). These data not only
confirm that in endomitotic Mk cells, GEF-H1 and ECT2 levels
decreased (albeit with different kinetics), but also suggest that
during Mk differentiation, loss of GEF-H1 predominates in low-
ploidyMks, whereas loss of ECT2 occurs later and predominates
in higher-ploidy endomitosis.
Ectopic Expression of GEF-H1 or ECT2 Causes
Low-Ploidy Mks In Vitro
To test whether the decreases in GEF-H1 and/or ECT2 cause
the sequential stages of endomitosis, we expressed exogenous
GEF-H1 or ECT2 by retroviral transduction of PreMegE cells,
which were then induced to differentiate with DM in which
80% of mitotic events are endomitotic. After 3 days in DM,
the ploidy of GFP-positive (control vector versus ECT2 overex-
pression versus GEF-H1 overexpression) CD41+ Mks was as-
sessed by flow cytometry. Enforced expression of ECT2 or
GEF-H1 did not affect the percentage of cells that were
CD41+ (Figure S2), suggesting that exogenous GEF-H1 or
ECT2 does not affect PreMegE differentiation down the Mk
lineage. Cells transduced with empty viral vector had a normal576 Developmental Cell 22, 573–584, March 13, 2012 ª2012 Elsevier Inc.Mk ploidy distribution. Although enforced
expression of either GEF-H1 or ECT2 resulted
in significantly decreased mean ploidy (Figures
5A and 5B), the ploidy profiles were signifi-
cantly different. GEF-H1 caused an increase
in 2N cells, although Mks that became 4Nwere still able to become highly polyploid (Figure 5A, middle).
In contrast, ECT2 expression led to accumulation at the 2N,
4N, and 8N stage with far fewer cells having >8N (Figure 5B,
right). We believe that the 8N peak in cells overexpressing
ECT2 represents the G2/M peak of cycling 4N cells. Expression
of GEF-H1 and ECT2 was confirmed by western blot (Figure 5D).
To evaluate whether enforced expression of GEF-H1 plus
ECT2 completely prevents endomitosis, we transduced
PreMegE cells with both GEF-H1 (with IRES-RFP) and ECT2
(with IRES-GFP) retroviruses. After 3 days in TPO, the ploidy
of CD41+ RFP+ and GFP+ (double-positive) cells was deter-
mined. Compared with cells only expressing GEF-H1 or
ECT2, the cells expressing both have more 2N cells, and far
fewer >4N cells (Figure 5C, far right, top). These data indicate
that exogenous expression of GEF-H1 prevents the progression
of cells from 2N to 4N in the first endomitotic event, whereas
exogenous expression of ECT2 prevents the subsequent >4N
endomitotic events to form highly polyploid Mks. Because
RhoA acts downstream of ECT2 and GEF-H1, we next tested
whether the dominant-negative RhoA mutant RhoA N19 can
block the effect on Mk ploidy caused by enforced expression
of ECT2 or GEF-H1 in Mks. As shown in Figure 5C (bottom),
the ability to make high-ploidy Mks was restored in cells
expressing both GEF-H1 and RhoA N19 or ECT2 and RhoA
N19 compared with only expressing GEF-H1 or ECT2 (Fig-
ure 5C, top).
To assess whether downregulation of GEF-H1 plays a role in
polyploidization of Mks in vivo, GEF-H1 transduced CD45.1
BM cells were transplanted into lethally irradiated WT CD45.2
mice. After 6 weeks, the ploidy of GFP-positive (control vector
versus GEF-H1 transduced) Mks was assessed. In agreement
with in vitro differentiation, ectopic expression of GEF-H1 re-
sulted in more 2N Mks (27.8%) compared with empty vector
(13.1%), leading to a decrease in the average ploidy (Figures
5E and 5F). However, as seen in vitro, those GEF-H1 transduced
cells that did become 4N were able to undergo subsequent
further polyploidization. These data demonstrate that enforced
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Figure 3. GEF-H1 and ECT2 Are Downregulated during Mk Differentiation
Data shown for freshly sorted (d0) PreMegE and MkP cells from WT mice, as well as PreMegEs cultured in DM for the time indicated.
(A) Relative levels of GEF-H1 mRNA are reduced during Mk differentiation. ***p < 0.005, versus value of PreMegE day 0.
(B) Relative levels of ECT2 mRNA were also decreased. ***p < 0.005, versus value of PreMegE day 0.
(C) The protein levels of GEF-H1 and ECT2 are reduced with different kinetics as shown by western blotting. Anti-a-tubulin was used as the loading control.
Relative protein level of each sample after normalization to tubulin and setting PreMegE level as 1 are indicated above each band.
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GEFs in Megakaryocyte EndomitosisGEF-H1 expression decreases the likelihood of 2N to 4N endo-
mitotic events in Mks in vivo.
Downregulation of GEF-H1 during Mk Differentiation Is
Mediated by MKL1
Our lab previously demonstrated that knockout of the transcrip-
tional cofactorMegakaryoblastic leukemia 1 gene (Mkl1) leads to
reduced Mk ploidy in vivo (Cheng et al., 2009). To study whether
the downregulation of GEF-H1 and/or ECT2 during Mk differen-
tiation is Mkl1 dependent, we analyzed GEF-H1 and ECT2
mRNA levels during Mk differentiation of PreMegEs and MkPs
from Mkl1/ and WT mice. GEF-H1 levels in both PreMegEs
and MkPs are more than 15 times higher in Mkl1/ mice than
in WT mice (Figure 6A). Unlike WT cells, there is little decrease
of GEF-H1 mRNA in Mkl1/ Mks differentiated in vitro. In
contrast, ECT2 mRNA levels are the same in Mkl1/ versus
WT cells (Figure 6B).
We next assessed GEF-H1 protein expression and localiza-
tion in Mkl1/ versus WT PreMegEs cultured for 1 day in
DM. GEF-H1 expression is much higher in Mkl1/ Mks
than WT, and it is localized to both the cell periphery and the
microtubule spindle compared with predominant spindle
localization in WT cells during normal mitosis (Figure 6C). No
obvious differences between WT and Mkl1/ cells were found
in ECT2 detection or localization (data not shown). As expected
with higher GEF-H1 levels in Mkl1/ PreMegEs and Mks, GTP-
bound active RhoA levels in PreMegEs with or without 24 hr
exposure to TPO are higher than WT (Figure S3). However,
the RhoA activity in Mkl1/ cells is able to decrease after
1 day in TPO, similar to WT cells (Figure S3). To further confirm
that GEF-H1 downregulation is MKL1 dependent, we assessed
the GEF-H1 mRNA levels in nonhematopoietic 293FT cells
transfected with control vector, WT, constitutively active, or
dominant-negative MKL1 constructs. WT MKL1 slightly
decreased GEF-H1, constitutively active MKL1 further de-
creased GEF-H1 levels, and dominant-negative MKL1 actually
increased GEF-H1 levels (Figures 6D and 6E). MKL1 is part ofDevelothe t(1;22)(p13;q13) chromosomal translocation, associated
with acute megakaryoblastic leukemia (Mercher et al., 2001;
Ma et al., 2001). To test whether GEF-H1 is dysregulated in
acute megakaryoblastic leukemia containing the MKL1 translo-
cation, we analyzed the levels of GEF-H1 and ECT2 in 6133
cells, a megakaryoblastic leukemia cell line derived from
a transgenic mouse in which MKL1 was knocked in down-
stream of exon 1 of RBM15 to allow expression of the
RBM15-MKL1 fusion product (Mercher et al., 2009), compared
with WT PreMegEs. As shown (Figure 6F), 6133 cells express
elevated GEF-H1 and ECT2 compared to normal MkP Pre-
MegEs. In summary, GEF-H1 is downregulated by MKL1 during
Mk differentiation, whereas the ECT2 decrease is MKL1 inde-
pendent, and acute megakaryoblastic leukemia cells have
increased GEF-H1 expression.
Knockdown of GEF-H1 Rescues the Ploidy Defect in
Mkl1–/– Mks
In order to test whether downregulation of GEF-H1 alone can
restore polyploidization in Mkl1/ Mks, we decreased GEF-H1
by shRNA inWT andMkl1/ PreMegEs, that were then differen-
tiated in DM. As expected, GEF-H1 shRNA had no effect on WT
Mk ploidy compared with a control shRNA targeting luciferase
(Figure 7A). Mks differentiated from Mkl1/ cells transduced
with control shRNA had lower ploidy than WT cells (Figure 7A).
However, transduction of Mkl1/ Mks with GEF-H1 shRNA
led to much higher ploidy (Figure 7A, far right). The average
ploidy for each condition (Figure 7B) demonstrates that shRNA
against GEF-H1 restores the ploidy level of Mkl1/ cells to
that of WT cells. The GEF-H1 shRNA construct was validated
in mouse NIH 3T3 cells, in which there was approximately 70%
knockdown (Figure 7C).
DISCUSSION
Our data confirm that there are two distinct stages of Mk endo-
mitosis. For the 2N to 4N transition, cleavage furrow ingressionpmental Cell 22, 573–584, March 13, 2012 ª2012 Elsevier Inc. 577
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Figure 4. GEF-H1 and ECT2 Are Reduced in Endomitotic Mks
(A) Cells were stained with anti-GEF-H1 (red), anti-a-tubulin (green), and DAPI. Examples of normal mitosis (i–iii, PreMegEs cultured in GM), 2N to 4N endomitosis
(iv–vi), andR4N endomitosis (vii–ix) are shown. GEF-H1 protein level is reduced at the 2N to 4N stage of endomitosis and increases at later stages (2 days) of
endomitosis.
(B) ECT2 protein, stained with anti-ECT2 antibody (red), is clearly detected in PreMegEs undergoing mitosis (i–iii), and at the 2N to 4N stage of endomitosis (iv–vi),
but ECT2 levels are reduced at later stages (2 days) of endomitosis (vii–ix).
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associated withR4N cells, there is little cleavage furrow ingres-
sion. Our data provide evidence that RhoA activation is absent
from the cleavage furrow during endomitotic cleavage, and
that two mitotic GEFs, GEF-H1 and ECT2, are downregulated
during Mk differentiation. Overexpression of GEF-H1 in differen-
tiating Mks leads to more 2N Mks, but for those cells that do
fail to complete cytokinesis, high levels of polyploidization are
still achievable. In contrast, exogenous ECT2 inhibits 4N poly-
ploid cells from undergoing endomitosis but does not affect
proliferation of 2N and 4N cells. Enforced overexpression of
both GEF-H1 and ECT2 completely prevents polyploidization
of primary Mks.
We conclude that decrease of GEF-H1 during megakaryocy-
topoiesis is mediated by the transcriptional cofactor MKL1,
based on the markedly elevated GEF-H1 expression in Mkl1/
Mks, and the downregulation of GEF-H1 in 293FT cells overex-
pressing constitutively active MKL1. The block of polyploid-
ization in Mkl1/ Mks can be restored by shRNA-mediated
downregulation of GEF-H1, further confirming that GEF-H1 is
downstream of MKL1.
Using primary murine PreMegEs and MkPs differentiated
in vitro down the Mk lineage with TPO, we observed late
cytokinesis defects in the first round of endomitosis, whereas
for later rounds of endomitosis (R4N), the majority of endomi-
tosis occurred without apparent cleavage furrow ingression.
These data differ from reports on endomitosis of human
CD34+-derived Mks, especially cord blood CD34+, in which
only about 30% of 2N cells undergo endomitosis, and the
majority of high-ploidy cells showed significant furrow ingres-
sion, and some high-ploidy cells were able to complete cytoki-
nesis and divide into two high-ploidy cells (Lordier et al., 2008;
Leysi-Derilou et al., 2010). The low endomitosis ratio at the 2N
stage of the human CD34+-derived Mks may be due to contam-
ination with other cell types, and the majority of immunofluo-578 Developmental Cell 22, 573–584, March 13, 2012 ª2012 Elsevierrescence images of those cells may represent normal mitotic
divisions. Alternatively, there may be intrinsic differences
between murine and human megakaryopoiesis, especially that
of cord blood, in which Mk ploidy is lower than in adults, indi-
cating fewer endomitotic cleavage events. Although the absence
of cleavage furrow formation in high-ploidy endomitosis has
been reported previously as being associated with a lack of
accumulation of RhoA (Lordier et al., 2008; Geddis andKaushan-
sky, 2006), the mechanism of cytokinesis failure in the early
rounds of endomitosis was previously unknown because RhoA
was correctly localized to the cleavage furrow at the 2N stage.
Here we show that this correctly localized RhoA is not activated
in cells undergoing endomitosis with a FRET-based RhoA
activity biosensor in live Mks.
We show that the mRNA and protein levels of two RhoA GEFs
involved in cytokinesis are decreased with different kinetics
during Mk differentiation: the reduction of GEF-H1 occurs at
the 2N to 4N stage, whereas the significant reduction of ECT2
protein occurs at 4N and higher stages. Forced expression of
GEF-H1 results in a higher percentage of Mks that are 2N,
although high-ploidy Mks can still form, whereas forced expres-
sion of ECT2 results in accumulation of 2N to 8N Mks, and
a lack of higher-ploidy Mks. Taken together, these data suggest
that loss of GEF-H1 and ECT2 play distinct roles in Mk poly-
ploidization: in low-ploidy cells, with correct ECT2 localization
at the central spindle, RhoA is recruited to the equatorial region,
but due to the lack of GEF-H1 protein, most of this RhoA is
inactive. In high-ploidy cells, despite restored levels of GEF-
H1, significantly decreased levels of ECT2 lead to failure of
RhoA recruitment to the equatorial region. GEF-H1 levels
decrease again in platelets (Figure S1). As we and others re-
ported previously (Halene et al., 2010; Patel et al., 2005), the
extensive microtubule network and actin cytoskeleton are
essential for Mk maturation, platelet formation, and function. It
is thus possible that the reappearance of GEF-H1, a uniqueInc.
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Figure 5. Differential Effects of Overexpressing GEF-H1 or ECT2 on Polyploidization of Mks
(A–C) PreMegE cells in GM were transduced with retroviral vectors (control and expressing individual GEFs) and cultured for 2 days, then transferred to DM for
3 days before the ploidy of each sample was assessed. (A) Shown is the effect of overexpressing control (GFP) virus, GEF-H1, or ECT2 encoding virus. Ploidy of
GFP+ cells in each condition is shown. The percentages of Mks in 2N, 4N, and R8N ploidy are indicated. (B) The average ploidy of Mk expressing GFP only
(control), GEF-H1, or ECT2 is compared. ***p < 0.005, versus control. (C) In this experiment, cells were transduced with two retroviral vectors (one encoding RFP
and the other GFP). Controls received vectors encoding only RFP and GFP. GEF-H1 (top, second panel) received GFP control plus GEF-H1-IRES-RFP vectors,
ECT2 (top, third panel) received ECT2-IRES-GFP plus control RFP vectors, the fourth panel (top) shows cells transduced with ECT2-IRES-GFP plus GEF-H1-
IRES-RFP. Samples in lower panel were transduced with RhoAN19-IRES-GFP together with RFP control (left), GEF-H1-IRES-RFP (middle), or ECT2-IRES-RFP
(right). Ploidy is shown for GFP+RFP+ (double-positive) cells.
(D) Western blot of HEL cells transduced with the indicated virus validates expression vectors.
(E) Overexpression of GEF-H1 also decreases polyploidization of Mks in vivo. CD45.1 BM cells were transduced with control (GFP only) or GEF-H1-IRES-GFP
virus, and transplanted into lethally irradiated CD45.2 mice. After 6 weeks, the ploidy of GFP-positive Mks was analyzed. Representative ploidy profiles from
GFP+ Mks expressing empty virus or GEF-H1 are shown.
(F) Average ploidy of GFP-positive Mks recovered 6 weeks posttransplant. *p < 0.05, versus the value of control.
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Figure 6. Downregulation of GEF-H1 Is
MKL1 Dependent
(A) The relative mRNA level of GEF-H1 is signifi-
cantly increased in Mkl1/ Mks, and shows very
little decrease with Mk differentiation. WT or
Mkl1/ PreMegEs or MkPs were cultured in DM
as indicated. ***p < 0.005, versus the corre-
sponding WT control.
(B and C) Relative ECT2 mRNA levels are the
same for WT and Mkl1/ cells (B). In both, ECT2
mRNA decreases during Mk differentiation. p >
0.1 for the values of Mkl1/ versus the corre-
sponding WT control, (C) PreMegEs cultured in
GM (mitotic controls, i–iii and vii–ix), and MkPs
cultured in TPO-only medium, which induces
endomitosis, were immunostained as indicated.
UnlikeWTMkPs (iv–vi), Mkl1/MkPs do not show
a loss of GEF-H1 protein level in response to TPO
induction (x–xii).
(D and E) 293FT cells were transduced with empty
vector (), WTMkl1 (WT), constitutively active (CA)
Mkl1, which lacks the actin binding domain, or
dominant-negative (DN) Mkl1, which lacks the
transcriptional activation domain but can still het-
erodimerize with endogenous Mkl1. Over-
expression of CA MKL1 significantly reduces
endogenous GEF-H1 mRNA (D) and protein (E)
levels compared to cells transduced with empty
vector (), WT Mkl1 (WT), and dominant-negative
(DN) Mkl1. GAPDH was used as a loading control
in (E). ***p < 0.005, and **p < 0.01, versus the value
of empty vector ().
(F) Quantitative RT-PCR reveals much higher
levels of GEF-H1 and ECT2 mRNA in the 6133 cell
line compared to WT PreMegEs with PreMegE
value set to 1. Values normalized to 18S RNA
(***p < 0.005).
Developmental Cell
GEFs in Megakaryocyte Endomitosismicrotubule-associated RhoA GEF, in higher-ploidy Mks may
be essential for subsequent Mk maturation, but not for platelet
function.
Our data from Mkl1/ mice and overexpression of constitu-
tively active (nuclear) MKL1 in 293FT cells suggest that MKL1
downregulates GEF-H1 mRNA, but not ECT2. MKL1 is a tran-
scriptional cofactor for SRF. MKL1 is upregulated and required
for Mk maturation and the formation of highly polyploid Mks
(Cheng et al., 2009). There is a confirmed SRF binding site close
to the GEF-H1 promoter region (Cooper et al., 2007). The mech-
anism by which MKL1 causes reduction of GEF-H1 during Mk
differentiation requires further study.
Acute megakaryoblastic leukemia is characterized by a
high percentage of immature, low-ploidy megakaryoblasts.
We showed that GEF-H1 and ECT2 levels are dramatically
increased in a megakaryoblastic leukemia cell line derived
from a mouse AMKL model in which the t(1;22) fusion protein is
encoded from the endogenous murine RBM15 locus. How
and whether the RBM15-MKL1 fusion protein regulates GEF-
H1 and/or ECT2 expression remains to be shown. One possi-580 Developmental Cell 22, 573–584, March 13, 2012 ª2012 Elsevierbility is that RBM15-MKL1 inhibits MKL1 activity, but this
would not explain the increase in ECT2 levels. Future
studies will need to explore the levels of GEF-H1 and ECT2
in AMKL patient samples, and whether targeting of either of
these GEFs could be used to promote Mk polyploidy and
maturation.
Furthermore, these mechanistic insights into the normal pol-
yploidization process of Mk differentiation have important impli-
cations for aneuploid cells, and their malignant transformation.
In normal Mks, although there are high levels of cyclin E
(Eliades et al., 2010) and D (Muntean et al., 2007) activity, which
are required to overcome the cell-cycle checkpoints in high-
ploidy cells undergoing endomitosis, proliferation is control-
led due to the lack of GEF-H1 and ECT2, which promotes
polyploidy and stops expansion. In contrast, abnormal poly-
ploid cells formed under stress conditions, with highly active
GEF-H1 and ECT2, can divide, expand, and transform to
malignant aneuploid cells. Therefore, GEF-H1 and ECT2 are
potential therapeutic targets for cancer cell proliferation and
expansion.Inc.
02
4
6
8
WT
P
lo
id
y
shLuc
shGEF-H1
A
anti-GEF-H1
anti-GAPDH
shRNA:  Lu
cife
ras
e
GE
F-H
1
#
 C
e
ll
s
CB
PI
WT   shLuciferase                                        WT  shGEF-H1                                                 shLuciferase                                                shGEF-H1
MKL1
MKL1 MKL1
27         15    19          3929         18    19          34 45         23    18          14 28       20     23          29
Figure 7. Knockdown of GEF-H1 Restores Polyploidy in Mkl1–/– Mks In Vitro
(A) WT or Mkl1/ PreMegEs were transduced with retrovirus encoding either shRNA-targeting luciferase or GEF-H1, as indicated. After TPO induced differ-
entiation, ploidy was assessed. A representative ploidy plot for each condition is shown. The percentages of Mks in 2N, 4N, 8N, andR16N ploidy are indicated.
(B) Average ploidy of these samples (***p < 0.005).
(C) Validation of shRNA-mediated knockdown of GEF-H1 protein in NIH 3T3 cells transducedwith the indicated constructs. GFP-positive shRNA-expressing cells
were sorted, and analyzed by western blot. GAPDH was used as the loading control.
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Cell Sorting
All mouse procedures were performed according to Yale University Animal
Care and Use Committee-approved protocols and complied with federal
laws. Murine BM cells were obtained by crushing hips, femurs, and tibias in
cold PBS with 1% FBS. After lineage depletion with the BD IMag Mouse
Hematopoietic Progenitor (Stem) Cell Enrichment kit (BD Biosciences, San
Jose, CA, USA), the remaining cells were stained with FITC anti-CD41, PE
anti-lineage markers, PE-Cy5 anti-CD150, PE-Cy7 anti-CD105, Alexa 647
anti-Sca1, and APC-Hy7 anti-CD117 antibodies (eBioscience, San Diego,
CA, USA; BioLegend, San Diego, CA, USA). The PreMegE population, defined
as the LinScaKit+CD41CD105CD150+, and MkP population, defined as
LinScaKit+CD41+, were separated using a FACSAria sorter. For sorting
MkPs from H2B-GFP transgenic mice (Jackson Laboratory, Bar Harbor, ME,
USA), eFluoro-450 labeled anti-CD41 antibody (eBioscience) was used.
Cell Culture, Mk Differentiation, and Western Blotting
For expansion, sorted PreMegEs were cultured at 13 106 cells/ml in GM con-
taining StemSpan (StemCell Technologies, Vancouver, Canada) supple-
mented with 30% BIT9500 (StemCell Technologies), 100 ng/ml murine SCF,
50 ng/ml murine Flt3-L, 10 ng/ml murine IL-3 (all purchased from PeproTech,
Rocky Hill, NJ, USA), 50 ng/ml murine TPO (from ConnStem, Cheshire,
CT, USA), and penicillin/streptomycin. For differentiation, PreMegEs and
MkPs were cultured in DM similar to the GM but with only a single cytokine,
20 ng/ml murine TPO. A total of 6,133 cells, a gift from Thomas Mercher
(Villejuif, France), were grown as described (Mercher et al., 2009). For westernDeveloblotting, about 1 3 105 cells per sample were washed with cold PBS, lysed in
RIPA buffer for 15min, and centrifuged at 18,0003 g for 15 min. Platelet lysate
was prepared as described (Halene et al., 2010), and 20 mg of lysate per
sample was analyzed by western blot with mouse anti-a-tubulin antibody
(1:2,000; Sigma-Aldrich), rabbit anti-GEF-H1 antibody (1:1,000; Upstate),
and rabbit anti-ECT2 antibody (1:500; Santa Cruz Biotechnology), and the cor-
responding secondary antibody. The density of protein bands was analyzed
with ImageJ.
Time-Lapse Video Microscopy
Primary murine MkPs from H2B-GFP transgenic mice were sorted and
cultured in 35 mm glass-bottom dishes (MatTeK, Ashland, MA, USA) in DM.
To maintain nonadherent cells within the field of view for time-lapse micros-
copy, 1% methylcellulose was added to increase the viscosity. Live-cell
imaging was performed using a VivaView system (Olympus; Japan) with
a 203 objective. DIC and green fluorescence images were taken every
5 min for 2 days with an Orca-R2 camera (Hamamatsu, Japan). Imaging
data were analyzed, compiled, and exported into QuickTime video with Meta-
Morph for VivaView software.
Immunofluorescent Staining and Confocal Analysis
PreMegE and MkP cells cultured as indicated were cytospun onto glass
slides, fixed with 3.7% formaldehyde for 15 min, and permeabilized with
0.1% Triton X-100 (Sigma-Aldrich) for 15 min. After blocking (PBS plus 3%
BSA), slides were incubated with mouse anti-a-tubulin plus rabbit anti-GEF-
H1 antibody (1:200; Upstate) or rabbit anti-ECT2 antibody (1:100; Santa
Cruz Biotechnology). Bound antibody was detected using Alexa 488-labeledpmental Cell 22, 573–584, March 13, 2012 ª2012 Elsevier Inc. 581
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secondary antibody, or Alexa 488-labeled anti-rabbit secondary antibody
and Alexa 555 anti-mouse secondary antibody (Invitrogen). Fluorescent
images were obtained on a Leica SP5 confocal microscope (Leica Microsys-
tems, Wetzlar, Germany).
Plasmids, Virus Production, and PreMegE Transduction
Details regarding plasmids can be found in the Supplemental Experimental
Procedures. For retrovirus production, in a T-175 flask, 90% confluent
HEK293 cells constitutively expressing Gag/Pol were transfected with 40 mg
pBabe-Puro-RhoA Biosensor, MigR1 empty vector control, MigR1-GEF-H1,
MigR1-ECT2, or Mieg3 RhoA N19 and 14 mg of VSVG packaging plasmid by
Lipofectamine 2000 (Invitrogen) per manufacturer’s instructions. Supernatant
collected at 48 and 72 hr was combined, spun at 3,700 3 g through Amicon
filters (Millipore, Billerica, MA, USA) to concentrate the virus to approximately
13 108 per ml, and aliquots were stored at80C. Freshly sorted 53 104 Pre-
MegE cells in GMwere infected with indicated viruses in the presence of poly-
brene (8 mg/ml) by spinfection at 900 3 g for 1 hr at 30C. After 2 days in GM,
some cells were switched to DM for 8 hr before FRET analysis or another
3 days for ploidy analysis.
FRET Analysis of RhoA Activation in Endomitotic Cells
RhoA activity during endomitosis was visualized using a widely used RhoA
biosensor FRET probe (Pertz et al., 2006). Two days after viral transduction,
DNA of live PreMegE cells was stained with Hoechst red 33342 for 15 min,
then the cells were washed and placed in DM or GM in a 35 mm glass-bottom
dish. After 8 hr, dividing cells in prometaphase expressing the RhoA biosensor
were identified by YFP-fluorescence and chromosome morphology by UV
excitation on a Leica SP5 confocal microscope equipped with temperature
and CO2 control. CFP, FRET, YFP, and DIC images were acquired using
a 633 NA 1.4 objective. The fluorescence emission resulting from excitation
with 458 (for CFP and FRET) and 514 (for YFP) nm laser lines from an argon
laser through an acousto-optical filter was detected with a prism spectropho-
tometer detection system, at a 490–500 nm spectral band width setting for
CFP and a 520–590 nm spectral band width setting for FRET and YFP. Image
analysis was performed using ImageJ essentially as described by Hodgson
et al. (2010). Briefly, after shading correction and background subtraction,
each CFP and the FRET image was multiplied with a binary threshold-based
mask to eliminate noise outside of the cell. Then, the FRET ratio image was
generated by dividing the raw FRET image with the CFP image.
Quantitative RT-PCR
Total RNA from 5 3 104 cells was isolated using the RNAqueous-Micro Kit
(Applied Biosystems, Foster City, CA, USA), and treated with RNase-free
DNase I. First-strand cDNA was produced with SuperScript II Reverse Tran-
scriptase (Invitrogen) and random primers (Invitrogen) with 20 ng RNA from
each sample. Gene expression levels were quantified on an iCycler iQ RT
machine (Bio-Rad, Hercules, CA, USA) with 2 ml of cDNA product from each
sample using TaqMan probes (Applied Biosystems) as follows: murine GEF-
H1: Mm00434757_m1; murine ECT2: Mm01289559_g1; and Eukaryotic18S
rRNA: Hs99999901_s1. Relative gene levels were calculated from standard
curves and normalized to 18 s levels.
Flow Cytometric Analysis of DNA Content and Surface Markers
In vitro differentiated Mks were stained with APC-conjugated anti-CD41 anti-
body, then fixed and permeabilized using BD cytofix/cytoperm on ice for
30 min. After incubation with RNAase at 37C for 30 min, nuclear DNA was
stained with 1 g/ml propidium iodide and analyzed using a FACSCalibur cy-
tometer (BD Biosciences) and FlowJo software (TreeStar, Ashland, OR,
USA). In experiments using MigR1 RFP vectors, the nuclear DNA was stained
with DAPI, and analyzed on a BD LSRII cytometer. To assay the Mk ploidy in
transplanted mice, BM was collected, red cells lysed with PharmLyse (BD
Biosciences), and ploidy analyzed as described above.
Murine BM Transplant
WT CD45.1 (B6.SJL-PtprcaPep3b/BoyJ mice) and CD45.2 (C57Bl6) mice
were purchased from the Jackson Laboratory. After treatment with
150 mg/kg 5FU for 4 days, red cell-depleted BM from 4- to 6-week-old582 Developmental Cell 22, 573–584, March 13, 2012 ª2012 ElsevierCD45.1 donor mice was transduced with empty vector or MigR1 GEF-H1
retrovirus by spinfection in StemSpan medium with 30% BIT9500, supple-
mented with 100 ng/ml SCF, 50 ng/ml TPO, 50 ng/ml Flt3 ligand, and
10 ng/ml IL-3. Lethally irradiated recipient C57Bl6/J mice were transplanted
with 1 million cells 24 hr after transduction. Transplant efficiencies were moni-
tored by detecting the CD45.1 ratio in the peripheral blood 4 weeks posttrans-
plantation. GFP-positive Mk ploidy from recipient mice was analyzed 6 weeks
posttransplant.
RNAi
The lentivirus pGIPZ vector containing shRNA-targeting GEF-H1 (RHS4430-
101128431) was obtained from Open Biosystems. The mir30 shRNA GEF-
H1 sequence was cut with restriction enzymes Hpa1 and Bsut1, and ligated
into the CMV-YFP-shRNA retroviral vector (gift from D. Wu, Yale University)
digested with Hpa1, and retrovirus produced as described above. CMV-YFP
vector containing shRNA-targeting luciferase was used as a control. Sorted
PreMegE cells from WT or Mkl1/mice (kind gift from Stephan Morris, Mem-
phis, TN, USA) were transduced with the shRNA viruses, and incubated for
3 days in GM followed by 3 days in DM, and the ploidy of YFP-positive cells
then assessed. To confirm the GEF-H1 shRNA efficiency, NIH 3T3 cells
were also transduced. After 3 days, YFP cells were sorted, andGEF-H1 protein
levels detected by western blot.
Statistical Analysis
Data are represented as mean ± SEM of at least three independent experi-
ments. Statistical significance was calculated with Student’s t test: *p <
0.05, **p < 0.01, ***p < 0.005.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Experimental
Procedures, and two movies and can be found with this article online at
doi:10.1016/j.devcel.2011.12.019.
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